Drug Shortage Resolved
Oxford Pharmaceutical's (Totowa, NJ) antidepressant drug “Marplan” (isocarboxazid, 10-mg dosage) has been removed from the US Food and Drug Administration’s list of drug shortages. Oxford resumed normal distribution of Marplan on May 27.
Marplan is a second-line treatment for depression offered as an option for patients who are unresponsive to other antidepressants such as selective serotonin reuptake inhibitors or traditional antidepressants such as amitriptyline.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.